Fig. 3From: A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function(a-c) Survival analyses of subgroups according to Child-Pugh class with ASAR score in the entire cohort. When applying ASAR score (cut-off = 4), overall survivals were significantly different in all enrolled patients as well as in patients with Child-Pugh class A or BBack to article page